Skip to main content
. 2021 Jul 2;14(13):3706. doi: 10.3390/ma14133706

Figure 1.

Figure 1

Schematic representation of current approaches for diagnosis and treatment of head and neck cancer and use of nanostructures to enhance efficiency of these methods. Note: CT: Computed tomography, PET: positron emission tomography, MRI: magnetic resonance imaging, ERCC1: excision repair cross complementing group 1, p16: cyclin-dependent kinase inhibitor 2A, IL8: interleukin-8, CCND1: cyclin D1, FGFR1: epidermal growth factor receptor group 1, NPs: nanoparticles.